Drug
Tozasertib clinical trials
Also written MK0457.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tozasertib is read from its arms, and is right about nine times in ten.
Testing it · 5
- A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)TerminatedPhase 1Merck Sharp & Dohme LLCNCT02532868Written as MK-0457
- MK0457 in Patients With Leukemia (0457-003)CompletedPhase 1Merck Sharp & Dohme LLCNCT00111683Written as MK0457
- A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00290550Written as MK0457
- A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)TerminatedPhase 1Merck Sharp & Dohme LLCNCT00500006Written as MK0457
- A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00405054Written as MK0457
Codes
What other systems call tozasertib · ClinicalTrials.gg INT004633
- MeSH (NLM) C484810tozasertibOne source NLM
- UNII (FDA) 234335M86KTOZASERTIBConfirmed FDA, NLM, Wikidata
- Wikidata Q6605919tozasertibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C98053TozasertibOne source FDA
- DrugBank DB19675One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C484810 | tozasertib | One source NLM |
| UNII (FDA) | 234335M86K | TOZASERTIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6605919 | tozasertib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C98053 | Tozasertib | One source FDA |
| DrugBank | DB19675 | — | One source Wikidata |
Also registered as tozasertib lactate (UNII CN8EF9N084).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.